By integrating our expertise in biocatalysis and chemical process development the Company can reduce difficult and/or expensive manufacturing processes to simpler routes of synthesis thereby producing cost effective solutions and valuable manufacturing intellectual property for the Company and its partners.

BioVerdant synergistically integrates our expertise in biotransformations and development of novel synthetic routes for the manufacture of active pharmaceutical compounds. The BioVerdant team has extensive industrial experience with broad expertise in developing novel chemical processes and implementing the syntheses on large scale for drug manufacture. Through the integration of chemical and biocatalytic retrosynthetic analyses, BioVerdant has the unique ability to provide novel solutions to overcome existing manufacturing difficulties as well as to reduce the cost of manufacturing processes. The Company’s scientists have demonstrated manufacturing scale biocatalytic routes that currently provide significant savings over first generation manufacturing routes, producing a significant impact on bottom-line drug profitability. In addition to the savings on manufacturing costs, the intellectual property will provide extended exclusivity including the composition of matter of key intermediates and the manufacturing process.